annual book value:
$363.82M+$280.01M(+334.11%)Summary
- As of today (June 22, 2025), HALO annual book value is $363.82 million, with the most recent change of +$280.01 million (+334.11%) on December 31, 2024.
- During the last 3 years, HALO annual book value has risen by +$166.87 million (+84.72%).
- HALO annual book value is now at all-time high.
Performance
HALO Book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly book value:
$482.27M+$118.45M(+32.56%)Summary
- As of today (June 22, 2025), HALO quarterly book value is $482.27 million, with the most recent change of +$118.45 million (+32.56%) on March 31, 2025.
- Over the past year, HALO quarterly book value has increased by +$304.46 million (+171.23%).
- HALO quarterly book value is now at all-time high.
Performance
HALO quarterly book value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Book value Formula
Book Value = Total Assets − Total Liabilities
HALO Book value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +334.1% | +171.2% |
| 3 y3 years | +84.7% | +85.3% |
| 5 y5 years | +296.5% | +730.9% |
HALO Book value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +334.1% | at high | +632.4% |
| 5 y | 5-year | at high | +334.1% | at high | +730.9% |
| alltime | all time | at high | +1220.1% | at high | +924.4% |
HALO Book value History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $482.27M(+32.6%) |
| Dec 2024 | $363.82M(+334.1%) | $363.82M(-19.6%) |
| Sep 2024 | - | $452.70M(+56.4%) |
| Jun 2024 | - | $289.42M(+62.8%) |
| Mar 2024 | - | $177.81M(+112.2%) |
| Dec 2023 | $83.81M(-50.6%) | $83.81M(-66.4%) |
| Sep 2023 | - | $249.18M(+65.0%) |
| Jun 2023 | - | $151.03M(+129.4%) |
| Mar 2023 | - | $65.85M(-61.2%) |
| Dec 2022 | $169.80M(-13.8%) | $169.80M(+75.1%) |
| Sep 2022 | - | $96.99M(-66.9%) |
| Jun 2022 | - | $293.17M(+12.6%) |
| Mar 2022 | - | $260.26M(+32.1%) |
| Dec 2021 | $196.95M(+30.4%) | $196.95M(-30.1%) |
| Sep 2021 | - | $281.67M(+135.2%) |
| Jun 2021 | - | $119.75M(+77.2%) |
| Mar 2021 | - | $67.59M(-55.2%) |
| Dec 2020 | $151.05M(+64.6%) | $151.05M(+52.6%) |
| Sep 2020 | - | $98.99M(-6.2%) |
| Jun 2020 | - | $105.58M(+81.9%) |
| Mar 2020 | - | $58.04M(-36.7%) |
| Dec 2019 | $91.77M(-63.1%) | $91.77M(-62.6%) |
| Sep 2019 | - | $245.35M(-5.7%) |
| Jun 2019 | - | $260.05M(+0.0%) |
| Mar 2019 | - | $260.05M(+4.5%) |
| Dec 2018 | $248.89M(+19.4%) | $248.89M(+3.8%) |
| Sep 2018 | - | $239.74M(-6.0%) |
| Jun 2018 | - | $254.93M(-3.8%) |
| Mar 2018 | - | $265.06M(+27.2%) |
| Dec 2017 | $208.37M(-741.5%) | $208.37M(+187.8%) |
| Sep 2017 | - | $72.39M(+24.5%) |
| Jun 2017 | - | $58.16M(-199.4%) |
| Mar 2017 | - | -$58.50M(+80.1%) |
| Dec 2016 | -$32.48M(-175.5%) | -$32.48M(+170.9%) |
| Sep 2016 | - | -$11.99M(-220.9%) |
| Jun 2016 | - | $9.92M(-66.3%) |
| Mar 2016 | - | $29.47M(-31.5%) |
| Dec 2015 | $43.00M(+4.0%) | $43.00M(+35.2%) |
| Sep 2015 | - | $31.80M(-36.7%) |
| Jun 2015 | - | $50.23M(+33.8%) |
| Mar 2015 | - | $37.55M(-9.2%) |
| Dec 2014 | $41.35M(-306.9%) | $41.35M(+3.5%) |
| Sep 2014 | - | $39.94M(-27.8%) |
| Jun 2014 | - | $55.30M(-17.2%) |
| Mar 2014 | - | $66.75M(-433.9%) |
| Dec 2013 | -$19.99M | -$19.99M(+473.4%) |
| Sep 2013 | - | -$3.49M(-131.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2013 | - | $11.14M(-64.8%) |
| Mar 2013 | - | $31.68M(-35.2%) |
| Dec 2012 | $48.85M(+348.2%) | $48.85M(-4.6%) |
| Sep 2012 | - | $51.19M(-26.1%) |
| Jun 2012 | - | $69.23M(-14.6%) |
| Mar 2012 | - | $81.06M(+643.7%) |
| Dec 2011 | $10.90M(-46.4%) | $10.90M(-59.7%) |
| Sep 2011 | - | $27.06M(+34.9%) |
| Jun 2011 | - | $20.05M(+48.4%) |
| Mar 2011 | - | $13.52M(-33.6%) |
| Dec 2010 | $20.35M(+194.8%) | $20.35M(-41.9%) |
| Sep 2010 | - | $35.00M(-347.9%) |
| Jun 2010 | - | -$14.12M(+342.3%) |
| Mar 2010 | - | -$3.19M(-146.2%) |
| Dec 2009 | $6.90M(-55.1%) | $6.90M(-58.4%) |
| Sep 2009 | - | $16.60M(-37.2%) |
| Jun 2009 | - | $26.43M(+573.6%) |
| Mar 2009 | - | $3.92M(-74.5%) |
| Dec 2008 | $15.38M(-73.4%) | $15.38M(-50.2%) |
| Sep 2008 | - | $30.89M(-22.1%) |
| Jun 2008 | - | $39.65M(-19.5%) |
| Mar 2008 | - | $49.27M(-14.7%) |
| Dec 2007 | $57.77M(+150.3%) | $57.77M(-11.0%) |
| Sep 2007 | - | $64.91M(-8.3%) |
| Jun 2007 | - | $70.76M(+73.0%) |
| Mar 2007 | - | $40.90M(+77.2%) |
| Dec 2006 | $23.08M(+26.8%) | $23.08M(+53.3%) |
| Sep 2006 | - | $15.05M(+4.4%) |
| Jun 2006 | - | $14.42M(-11.4%) |
| Mar 2006 | - | $16.28M(-10.6%) |
| Dec 2005 | $18.21M(+22.8%) | $18.21M(+226.7%) |
| Sep 2005 | - | $5.57M(-39.6%) |
| Jun 2005 | - | $9.22M(-22.8%) |
| Mar 2005 | - | $11.95M(-19.4%) |
| Dec 2004 | $14.82M(+3865.8%) | $14.82M(+726.5%) |
| Sep 2004 | - | $1.79M(-63.5%) |
| Jun 2004 | - | $4.91M(-29.4%) |
| Mar 2004 | - | $6.96M(+1761.8%) |
| Dec 2003 | $373.80K(-198.5%) | $373.80K(+489.6%) |
| Sep 2003 | - | $63.40K(-12.3%) |
| Jun 2003 | - | $72.30K(-6.7%) |
| Mar 2003 | - | $77.50K(-120.4%) |
| Dec 2002 | -$379.60K(-1764.9%) | -$379.60K(-387.1%) |
| Sep 2002 | - | $132.20K(-8.3%) |
| Jun 2002 | - | $144.20K(+339.6%) |
| Mar 2002 | - | $32.80K |
| Dec 2001 | $22.80K | - |
FAQ
- What is Halozyme Therapeutics annual book value?
- What is the all time high annual book value for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual book value year-on-year change?
- What is Halozyme Therapeutics quarterly book value?
- What is the all time high quarterly book value for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly book value year-on-year change?
What is Halozyme Therapeutics annual book value?
The current annual book value of HALO is $363.82M
What is the all time high annual book value for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual book value is $363.82M
What is Halozyme Therapeutics annual book value year-on-year change?
Over the past year, HALO annual book value has changed by +$280.01M (+334.11%)
What is Halozyme Therapeutics quarterly book value?
The current quarterly book value of HALO is $482.27M
What is the all time high quarterly book value for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly book value is $482.27M
What is Halozyme Therapeutics quarterly book value year-on-year change?
Over the past year, HALO quarterly book value has changed by +$304.46M (+171.23%)